Literature DB >> 2884518

Treatment of idiopathic orthostatic hypotension with xamoterol.

H Yamashita, O Yahara, N Hasebe, Y Kawamura, A Obara, H Honda, T Kimura, S Onodera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2884518     DOI： 10.1016/s0140-6736(87)90618-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  R Furlong; R N Brogden
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

2.  Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.

Authors:  N Galiè; M Metalli; R Zannoli; G Binetti; A Branzi; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

3.  A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy.

Authors:  P J Leslie; C Thompson; B F Clarke; D J Ewing
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

4.  Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.

Authors:  J Mehlsen; C Stadeager; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.